- Home
- BTAI vs CLWT Comparison
BTAI vs CLWT Comparison
Compare BTAI & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- CLWT
- Stock Information
- Founded
- BTAI 2017
- CLWT 1971
- Country
- BTAI United States
- CLWT Hong Kong
- Employees
- BTAI N/A
- CLWT N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- CLWT Professional and commerical equipment
- Sector
- BTAI Health Care
- CLWT Consumer Discretionary
- Exchange
- BTAI Nasdaq
- CLWT Nasdaq
- Market Cap
- BTAI 8.3M
- CLWT 8.9M
- IPO Year
- BTAI 2018
- CLWT 1997
- Fundamental
- Price
- BTAI $1.93
- CLWT $1.15
- Analyst Decision
- BTAI Buy
- CLWT
- Analyst Count
- BTAI 5
- CLWT 0
- Target Price
- BTAI $34.60
- CLWT N/A
- AVG Volume (30 Days)
- BTAI 289.2K
- CLWT 15.2K
- Earning Date
- BTAI 08-05-2025
- CLWT 04-30-2025
- Dividend Yield
- BTAI N/A
- CLWT N/A
- EPS Growth
- BTAI N/A
- CLWT N/A
- EPS
- BTAI N/A
- CLWT 0.10
- Revenue
- BTAI $1,852,000.00
- CLWT $15,383,000.00
- Revenue This Year
- BTAI $5.03
- CLWT N/A
- Revenue Next Year
- BTAI $291.01
- CLWT N/A
- P/E Ratio
- BTAI N/A
- CLWT $12.09
- Revenue Growth
- BTAI 5.47
- CLWT N/A
- 52 Week Low
- BTAI $1.17
- CLWT $1.01
- 52 Week High
- BTAI $21.92
- CLWT $1.70
- Technical
- Relative Strength Index (RSI)
- BTAI 56.97
- CLWT 48.83
- Support Level
- BTAI $1.69
- CLWT $1.07
- Resistance Level
- BTAI $2.08
- CLWT $1.17
- Average True Range (ATR)
- BTAI 0.20
- CLWT 0.04
- MACD
- BTAI 0.02
- CLWT 0.00
- Stochastic Oscillator
- BTAI 61.84
- CLWT 50.00
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About CLWT Euro Tech Holdings Company Limited
Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.